Lawrence C. Swayne - Concepedia

Author

Lawrence C. Swayne

Morristown Medical Center

Also Known As

L C Swayne, L. C. Swayne, LAWRENCE C. SWAYNE, Lawrence C Swayne, Lawrence C. Swayne, Martha G. Fasciano

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Morristown Medical Center Center for Molecular Medicine and Immunology Columbia University

About

Lawrence C. Swayne is an author at Morristown Medical Center specializing in medicine, health sciences, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	884
2	Health Sciences	11	11	430
3	Public Health	1	1	16
4	Social Sciences	1	1	13
5	Allergy	1	1	10

Lawrence C. Swayne

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. Thomas M. Behr, Robert M. Sharkey, Malik E. Juweid, PubMed	1997	121
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma. Malik E. Juweid, Edward A. Stadtmauer, George Hajjar, PubMed Initial Therapeutic ResultsImmunologyImmunotherapyHematological MalignancyRadiation Medicine	1999	119
Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. Malik E. Juweid, Robert M. Sharkey, A Markowitz, PubMed Hematological MalignancyLymphoid NeoplasiaMurine Ll2MedicineMalignant Blood Disorder	1995	114
CT and MR Imaging in Cystic Abdominal Lymphangiomatosis Douglas P. Cutillo, Lawrence C. Swayne, Jim Cucco, Journal of Computer Assisted Tomography Multiple Organ InvolvementCystic Abdominal LymphangiomatosisMedical ImagingSurgical PathologyHistopathology	1989	87
Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Robert M. Sharkey, Malik Juweid, Jerry Shevitz, PubMed Tumor BiologyCancer ImmunosurveillanceMedicineMmn-14 MabImmunology	1995	84
Phase I/II trial of131I-MN-14 F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma Malik E. Juweid, George Hajjar, Lawrence C. Swayne, Cancer	1999	83
Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR. Malik Juweid, George Hajjar, Rhona Stein, PubMed	2000	71
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. Malik Juweid, Robert M. Sharkey, Thomas M. Behr, PubMed	1996	63
Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. Malik Juweid, Robert M. Sharkey, Thomas M. Behr, PubMed	1996	63
Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. Malik E. Juweid, Robert M. Sharkey, Thomas M. Behr, Journal of Clinical Oncology	1996	62

Page 1